Therefore, in an effort to identify novel pathways that could be targeted for intervention in the pre-clinical period of RA in order to avert clinical disease, we investigated whether adiponectin was associated with inflammatory markers in individuals at risk for RA, and whether autoimmunity modifies these associations. The gene discussed is ADIPOQ; the disease is rheumatoid arthritis.